Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | LIMK1 | P53667 | 13/20 | 0.37 |
| ▸ | PRKDC | P78527 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | F9 | P00740 | 1/20 | 0.34 |
| ▸ | LIMK2 | P53671 | 2/20 | 0.33 |
| ▸ | TNKS | O95271 | 1/20 | 0.33 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.33 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.33 |
| ▸ | WHR1 | P49842 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22195844 | 1.00 | ALOX5 (0.44) | ALOX5LIMK1PRKDCMEN1KMT2A | |
| SCHEMBL22195735 | 1.00 | ALOX5 (0.44) | ALOX5LIMK1PRKDCMEN1KMT2A | |
| SCHEMBL22195492 | 0.97 | ALOX5 (0.46) | ALOX5LIMK1PRKDCMEN1KMT2A | |
| SCHEMBL22195742 | 0.97 | ALOX5 (0.46) | ALOX5LIMK1PRKDCMEN1KMT2A | |
| SCHEMBL22195819 | 0.96 | ALOX5 (0.42) | ALOX5LIMK1PRKDCMEN1KMT2A | |
| SCHEMBL22195667 | 0.96 | ALOX5 (0.42) | ALOX5LIMK1PRKDCMEN1KMT2A | |
| SCHEMBL22195668 | 0.96 | ALOX5 (0.42) | ALOX5LIMK1PRKDCMEN1KMT2A | |
| SCHEMBL22195824 | 0.96 | ALOX5 (0.42) | ALOX5LIMK1PRKDCMEN1KMT2A | |
| SCHEMBL22329481 | 0.95 | ALOX5 (0.41) | ALOX5LIMK1PRKDCMEN1KMT2A | |
| SCHEMBL22195717 | 0.95 | ALOX5 (0.41) | ALOX5LIMK1PRKDCMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11581494-B2 | Organic light emitting device | LG CHEM, LTD. (KR) | 2023-02-14 | — | — | US | disclosed |
| US-20210230182-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2021-07-29 | — | — | US | disclosed |
| US-20200259098-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2020-08-13 | — | — | US | disclosed |
| WO-2020141949-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2020-07-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210230182-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, CYP1A1 | ALOX5 629/4885LIMK1 290/4885PRKDC 4560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.